Morgan Stanley cuts Pfizer target price to $26 from $28
PFE•Morgan Stanley cut its target price for Pfizer to $26 from $28.
Related News
Blackstone closes fourth European direct lending fund
BX•
RELX presents strategy to accelerate STM revenue growth
RELX•
Addus HomeCare Corp.: Barclays raises target price to $101 from $96
ADUS•
Waters Corporation: Barclays raises target price to $530 from $500
WAT•
Fiserv, Inc.: Barclays raises target price to $59 from $50
FISV•